Login

Mosunetuzumab

Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company
Lunsumio 1 mg and 30 mg concentrate for solution for infusion
No Recent Update
SPC PIL No A
Mosunetuzumab
 Roche Registration GmbH
Lunsumio 5 mg and 45 mg solution for injection
No Recent Update
SPC PIL No A
Mosunetuzumab
 Roche Registration GmbH